<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR123">
 <label>123.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhu</surname>
    <given-names>Q</given-names>
   </name>
   <name>
    <surname>McAuliffe</surname>
    <given-names>JM</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>NK</given-names>
   </name>
   <name>
    <surname>Palmer-Hill</surname>
    <given-names>FJ</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>CF</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>B</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab</article-title>
  <source>J Infect Dis</source>
  <year>2011</year>
  <volume>203</volume>
  <fpage>674</fpage>
  <lpage>682</lpage>
  <pub-id pub-id-type="doi">10.1093/infdis/jiq100</pub-id>
  <?supplied-pmid 21208913?>
  <pub-id pub-id-type="pmid">21208913</pub-id>
 </element-citation>
</ref>
